- P/E Ratio
- 13.10
- Earnings
- $11.43M
- Price change (1 year)
- +45.91%
- Price change (1 day)
- +0.42%
FTIRPharmaceutical Substances and Products
Market Capitalization of Iran Parenteral
Market capitalization (market cap): 150.31 million US dollars
The latest available market capitalization of Iran Parenteral (FTIR), an Iranian listed company, is 150.31 million US dollars. Iran Parenteral ranks 97 by market capitalization among the Iranian listed companies.
Market capitalization is the market value of a listed company's outstanding shares. It measures equity value, not revenue, total assets, or enterprise value. Changes in market cap are not stock returns: they also reflect changes in share count and the exchange rate.
Iran Parenteral ranks 5 by market capitalization in Iran's Pharmaceutical Substances and Products sector among the listed companies by this site; this sector ranking covers 49 listed companies. Iran Parenteral represents approximately 4.42% of the total market capitalization of companies in Iran's Pharmaceutical Substances and Products sector. Over the past year, the market cap of Iran Parenteral has increased by 39.49%, with 42.72 million US dollars added to its market cap. According to the Iran Parenteral’s announcement, company’s annual profit is 11.43 million US dollars. Using the latest available data, the P/E ratio of Iran Parenteral is 13.1.
Iran Parenteral Market-Cap History
The latest recorded market capitalization of Iran Parenteral was 150.89 million US dollars on 1 November 2026. Over the full period of available data, this company's market cap has increased by 525.09%, with approximately 126.75 million US dollars added to its market cap.
Latest Market Cap by Year
| Year | Market cap | Change |
|---|---|---|
| 2026 | $150.89M | ▲ 56.24% |
| 2025 | $96.58M | ▲ 35.29% |
| 2024 | $71.39M | ▼ 34.45% |
| 2023 | $108.91M | ▲ 38.27% |
| 2022 | $78.77M | ▲ 20.48% |
| 2021 | $65.38M | ▼ 11.36% |
| 2020 | $73.76M | ▼ 5.97% |
| 2019 | $78.44M | ▲ 70.23% |
| 2018 | $46.08M | ▼ 35.56% |
| 2017 | $71.51M | ▼ 50.06% |
| 2016 | $143.19M | ▲ 247.69% |
| 2015 | $41.18M | ▼ 18.08% |
| 2014 | $50.27M | ▲ 6.09% |
| 2013 | $47.38M | ▲ 343.07% |
| 2012 | $10.69M | ▼ 52.75% |
| 2011 | $22.63M | — |
Other Companies in the Pharmaceutical Substances and Products sector
| Sector rank / Ticker / Company | Market cap | Price | Price change (1 day) |
|---|---|---|---|
| 1 ABDI Dr. Abidi Lab. | $482.32M | $0.008613 | -2.49% |
| 2 DTIP Tamin Daroo | $349.15M | $0.0109 | -2.21% |
| 3 DPAK Daroupakhsh P. | $213.75M | $0.004127 | +2.71% |
| 4 DARO Daroupakhsh | $192.74M | $0.0229 | -0.96% |
| 6 DPHZ Daana Pharma Co | $124.98M | $0.008679 | -2.58% |